Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant.
作者信息
Pabon Cindy M, Li Zhiguo, Hennig Therese, de Castro Carlos, Neff Jadee L, Horwitz Mitchell E, LeBlanc Thomas W, Long Gwynn D, Lopez Richard D, Sung Anthony D, Chao Nelson, Gasparetto Cristina, Sarantopoulos Stefanie, Adams Donna B, Erba Harry, Rizzieri David A
机构信息
Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Department of Biostatistics and Bioinfomatics, Duke University, Durham, NC, USA.
出版信息
Blood Cancer J. 2021 May 16;11(5):92. doi: 10.1038/s41408-021-00481-9.
Abstract
摘要
相似文献
1
Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant.急性髓系白血病的形态学无白血病状态足以成功进行异基因造血干细胞移植。
Blood Cancer J. 2021 May 16;11(5):92. doi: 10.1038/s41408-021-00481-9.
2
Haploidentical unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT.亲缘半相合非亲缘异基因造血干细胞移植治疗复发/难治性急性髓系白血病：来自 EBMT 急性白血病工作组的 1578 例患者报告。
Haematologica. 2019 Mar;104(3):524-532. doi: 10.3324/haematol.2017.187450. Epub 2018 Oct 25.
3
Time-to-Event Ratio to Predict Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation?用于预测接受异基因造血细胞移植的急性髓系白血病患者预后的事件发生时间比？
Biol Blood Marrow Transplant. 2017 Oct;23(10):1804-1808. doi: 10.1016/j.bbmt.2017.06.016. Epub 2017 Jul 5.
4
Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes.异基因造血干细胞移植克服了伴有骨髓发育异常相关改变的急性髓系白血病的不良预后。
Leuk Lymphoma. 2016;57(1):76-80. doi: 10.3109/10428194.2015.1063148.
5
Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes.异基因造血干细胞移植后急性髓系白血病髓外复发：发生率、危险因素和结局。
Haematologica. 2013 Feb;98(2):179-84. doi: 10.3324/haematol.2012.073189. Epub 2012 Oct 12.
6
Impact of comorbidities constituting the hematopoietic cell transplant (HCT)-comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia.构成造血细胞移植（HCT）合并症指数的合并症对接受异基因造血细胞移植治疗急性髓系白血病患者结局的影响。
Eur J Haematol. 2018 Feb;100(2):198-205. doi: 10.1111/ejh.13000. Epub 2017 Dec 13.
7
Leukemia burden and outcome of allogeneic transplant in acute myelogenous leukemia.
Biol Blood Marrow Transplant. 2006 Jun;12(6):691-2. doi: 10.1016/j.bbmt.2006.01.011.
8
Obesity is correlated with poor outcome after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia.肥胖与急性白血病患者异基因造血干细胞移植后的不良预后相关。
Jpn J Clin Oncol. 2020 Aug 4;50(8):889-896. doi: 10.1093/jjco/hyaa053.
9
Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation.异体造血细胞移植后未缓解的白血病患者长期生存的影响因素。
J Exp Clin Cancer Res. 2011 Apr 10;30(1):36. doi: 10.1186/1756-9966-30-36.
10
Allogeneic hematopoietic stem cell transplantation could improve the survival of acute myeloid leukemia patients with ASXL1 mutations.异基因造血干细胞移植可改善 ASXL1 突变的急性髓系白血病患者的生存。
Hematology. 2021 Dec;26(1):340-347. doi: 10.1080/16078454.2021.1905356.
引用本文的文献
1
Characterization of a multidisciplinary team's role in hospital discharge for patients receiving hypomethylating agents with venetoclax as induction therapy for acute myeloid leukemia.对一个多学科团队在急性髓系白血病患者接受以维奈克拉为诱导疗法的去甲基化药物治疗后的出院过程中所扮演角色的特征分析。
Support Care Cancer. 2023 Mar 21;31(4):224. doi: 10.1007/s00520-023-07664-z.
2
A retrospective comparison of salvage intensive chemotherapy venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML).复发/难治性急性髓系白血病（AML）患者挽救性强化化疗联合维奈克拉方案的回顾性比较
Ther Adv Hematol. 2022 Mar 23;13:20406207221081637. doi: 10.1177/20406207221081637. eCollection 2022.
本文引用的文献
1
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.单倍体相合与同胞相合移植治疗急性髓系白血病完全缓解 1 期的结果。
Blood Adv. 2019 Jun 25;3(12):1826-1836. doi: 10.1182/bloodadvances.2019000050.
2
Cord-Blood Transplantation in Patients with Minimal Residual Disease.微小残留病患者的脐血移植
N Engl J Med. 2016 Sep 8;375(10):944-53. doi: 10.1056/NEJMoa1602074.
3
Hematologic Recovery after Pretransplant Chemotherapy Does Not Influence Survival after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients.急性髓系白血病患者移植前化疗后的血液学恢复不影响异基因造血细胞移植后的生存。
Biol Blood Marrow Transplant. 2015 Aug;21(8):1425-30. doi: 10.1016/j.bbmt.2015.03.022. Epub 2015 Mar 31.
4
Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial.中高危急性髓系白血病患者的造血细胞移植：来自随机 Study Alliance Leukemia（SAL）AML 2003 试验的结果。
Leukemia. 2015 May;29(5):1060-8. doi: 10.1038/leu.2014.335. Epub 2014 Dec 1.
5
Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia.高危急性髓系白血病患者化疗诱导再生障碍期行异基因造血细胞移植的早期干预。
Leukemia. 2013 Oct;27(10):2068-72. doi: 10.1038/leu.2013.142. Epub 2013 May 7.
6
Conditioning with fludarabine alone and allogeneic transplantation as a successful rescue therapy for persistent, severe iatrogenic aplasia after relapse of acute myeloid leukemia.单独使用氟达拉滨预处理及异基因移植作为急性髓系白血病复发后持续性严重医源性再生障碍的成功挽救治疗方法。
Bone Marrow Transplant. 2007 Jan;39(1):53-4. doi: 10.1038/sj.bmt.1705541. Epub 2006 Nov 20.
7
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.造血细胞移植（HCT）特异性合并症指数：一种用于异基因造血细胞移植前风险评估的新工具。
Blood. 2005 Oct 15;106(8):2912-9. doi: 10.1182/blood-2005-05-2004. Epub 2005 Jun 30.
8
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.急性髓系白血病治疗试验的诊断、反应标准标准化、治疗结果及报告标准国际工作组修订建议
J Clin Oncol. 2003 Dec 15;21(24):4642-9. doi: 10.1200/JCO.2003.04.036.
9
Persistent aplasia after chemotherapy for acute myeloid leukaemia treated with stem cell transplantation from a matched unrelated donor after dose-reduced conditioning.在采用剂量降低的预处理方案后，接受来自匹配无关供者的干细胞移植治疗的急性髓性白血病患者化疗后持续发育不全。
Br J Haematol. 2002 Aug;118(2):442-4. doi: 10.1046/j.1365-2141.2002.03742.x.
Zotero 插件